GLP-1 receptor agonists hold key market opportunities due to their effectiveness in diabetes and obesity management, ...

Clinical trials and equitable care pathways are needed to build on early evidence of benefit Substance use disorders (SUDs) are common and burdensome for patients, families, and health systems,12 yet ...

Opportunities in the GLP-1 receptor agonist market include the development of new diabetes and obesity treatments with high efficacy, a growing product pipeline, and increasing R&D investments. Rising ...

Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other ...

Por JOHN WAWROWLos Bills de Buffalo acordaron adquirir al receptor abierto D.J. Moore de los Bears de Chicago el jueves, según dijeron a The Associated Press dos personas con conocimiento del ...

GoodRx reports that GLP-1 medications will expand in use and accessibility, with new oral options and evolving insurance ...

The researchers detected a specific delay of about 18 milliseconds between the waves in the visual cortex and the ...

Ohio University researchers have discovered what may be a new way to fight lung cancer that is resistant to other treatments.

Dedifferentiated liposarcoma lacks effective IGF-1→PPAR-γ adipogenic signaling due to epigenetic silencing of PPAR-γ2, with ...

Amylyx (AMLX) downgraded to Buy after AMX0035 PSP halt; focus shifts to avexitide Phase 3 with Q3 2026 data and strong cash ...

“Overall, the study reinforces that GLP-1 receptor agonists are unlikely to produce durable weight loss if used as short term interventions without longer term management plans. For many patients, ...

Understanding the Testosterone-Acne Connection If you thought acne breakouts were only a teenage problem, think again. Testosterone — the same hormone that fueled those adolescent flare-ups ...